Prot# CVT-301-009: A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder) when Administered for Early Morning OFF Symptoms in Patients with Parkinson's Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date10/11/16 → 10/11/19

Funding

  • Covance Inc. (Prot# CVT-301-009 // Prot# CVT-301-009)
  • Acorda Therapeutics, Inc (Prot# CVT-301-009 // Prot# CVT-301-009)